---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-009611"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2026-03-24T23:59:59+00:00"
generated_at: "2026-05-15T09:13:53.493769+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals stockholders approve increased evergreen share reserve cap at annual meeting

## Summary
- Stockholder approved Amendment No. 1 to 2021 Omnibus Incentive Plan, effective March 23, 2026.
- New annual share increase is lesser of 3,187,234 shares, 5% of outstanding, or Board-determined amount.
- Class I directors Chaim Hurvitz and Michael Taylor re-elected with 9.86M and 9.89M For votes.
- Appointment of Weinberg & Company as auditor ratified with 17.35M For (98.5% of votes cast).
- Non-binding advisory vote on named executive officer compensation passed with 9.97M For.

## SEC filing metadata
- accession: 0001437749-26-009611
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2026-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774926009611/0001437749-26-009611-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926009611/nrxp20260324_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-009611
- JSON: https://secwatch.observer/filing/0001437749-26-009611.json
- Plain text: https://secwatch.observer/filing/0001437749-26-009611.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.